✦ LIBER ✦

High remission rates in the treatment of small cell lung cancer (SCLC) with etoposide and splitted doses of cisplatin (CDDP) — A phase II study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of etoposide and splitt

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II trial of etoposide and split-do

✍ Matsui, Yusaku; Kado, Masao; Izumi, Takateru 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A phase II study of cyclophosphamide / a

✍ Hara, N.; Ichinose, Y.; Kuba, M.; Ichikawa, Y.; Ninomiya, K.; Shima, K.; Yamamot 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II study of weekly high-dose cis

✍ André Planting; Siang Kho; Maria van der Burg; H. Goey; J. Schellens; Martin van 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 107 KB